- Report
- August 2023
- 70 Pages
South Korea
From €4404EUR$4,750USD£3,702GBP
- Report
- October 2022
- 70 Pages
Africa
From €4404EUR$4,750USD£3,702GBP
- Report
- August 2020
- 150 Pages
Global
From €3940EUR$4,250USD£3,312GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €464EUR$500USD£390GBP
Nesina is a brand of Endocrine and Metabolic Disorders Drugs, which are used to treat conditions such as diabetes, obesity, and hyperlipidemia. These drugs are designed to help regulate hormones and metabolism, and can be used to help manage blood sugar levels, reduce cholesterol, and promote weight loss. Nesina is a combination of two drugs, alogliptin and pioglitazone, which work together to help control blood sugar levels. It is available in tablet form and is taken once daily.
Nesina is manufactured by Takeda Pharmaceuticals, and is available in the United States, Canada, and Europe. Other companies that produce Endocrine and Metabolic Disorders Drugs include Novo Nordisk, Sanofi, and Merck. Show Less Read more